|
ACG is committed to keeping members abreast of current clinical
updates on disease treatment. We offer Clinical Updates through
practice guidelines and research published in The American
Journal of Gastroenterology and Nature Clinical Practice
Gastroenterology & Hepatology. The American Journal of
Gastroenterology is available for free to all ACG Members.
ACG Members, Fellows (FACG), Masters, and International Members
qualify for a free subscription to Nature Clinical Practice
Gastroenterology & Hepatology. Members also receive clinical
updates twice-weekly through ACG’s e-newsletter, ACG SmartBrief,
that delivers summaries of the latest news. ACG also publishes
special papers and monographs throughout the year. New in 2006,
Quality Indicators for Endoscopy, a series of five papers written
jointly with ASGE.
To learn more about ACG’s Clinical Updates, see below.
The College publishes guidelines on gastrointestinal diseases
in the American Journal of Gastroenterology that have been developed
and reviewed under the auspices of the ACG Practice Parameters
Committee.
Diagnosis
and Management of Achalasia (December 1999)
Diagnosis, Surveillance and Therapy of Barrett’s
Esophagus (March 2008)
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis (September 2007)
Diagnosis, Treatment and Surveillance for Patients with Colorectal Polyps (November 2000)
Management of Crohn’s
Disease in Adults (March 2001)
Diagnosis and Management of C. difficile-Associated Diarrhea and Colitis (May 1997)
Acute Infectious Diarrhea in Adults (November 1997)
Diagnosis and Management of Diverticular Disease of the Colon in Adults (November 1999)
Management of Dyspepsia (October 2005)
Esophageal
Cancer (December 1999)
Diagnosis and Treatment of Esophageal Diseases Associated with HIV Infection (November 1996)
Esophageal Reflux Testing (March 2007)
Diagnosis
and Management of Fecal Incontinence (2004)
Diagnosis and Treatment of Gastroesophageal Reflux Disease (January 2005)
Management of the Adult Patient with Acute Lower Gastrointestinal Bleeding (August 1998)
Diagnosis and Treatment of Gastrointestinal Bleeding Secondary to Portal Hypertension (July 1997)
Management of Helicobacter pylori Infection(August 2007)
Hepatic
Encephalopathy (July 2001)
Liver
Disease in the Pregnant Patient (July 1999)
Alcoholic
Liver Disease (November 1998)
Treatment
and Prevention NSAID-Induced Ulcers (November 1998)
Diagnosis and Management of Neoplastic Pancreatic Cysts (October 2007)
Acute
Pancreatitis (October 2006)
Ulcerative
Colitis in Adults (July 2004)
Measuring
the Quality of Endoscopy
Quality
Indicators for Gastrointestinal Endoscopic Procedures: An Introduction
Quality
Indicators for Colonoscopy
Quality
Indicators for Esophagogastroduodenoscopy
Quality
Indicators for Endoscopic Retrograde Cholangiopancreatography
Quality
Indicators for Endoscopic Ultrasonography
Are hospitals and health insurance plans exposed to potential
litigation if they don't establish guidelines for determining competency
in providing endoscopic procedures? ACG in cooperation with ASGE,
has published "Ensuring Competence in Endoscopy" which
helps to answer this question. Along with the joint publication,
a legal memorandum from a nationally-renowned litigation law firm,
Williams & Connolly, is included. ACG members will receive
a copy in the mail and ACG is also mailing a copy to all hospitals
and health plans across the country. PDF's of each may also be
found by clicking on one of the links below.
Ensuring
Competence in Endoscopy (for the GI physician)
Ensuring
Competence in Endoscopy Executive Briefing (for the hospital
or health plan administrator)
Highlights from the current issue
Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes
In this study, investigators sought to describe the treatment and response rates of severe colitis in pregnancy, and to assess the effects of a severe relapse of colitis during pregnancy on birth outcomes. Performing a case control study of pregnant patients with IBD hospitalized for a disease relapse at two large treatment centers between 1989 and 2001, details of management of disease relapse and maternal and fetal outcomes were recorded. (more)
Small Intestinal Bacterial Overgrowth in Patients Suffering From Scleroderma: Clinical Effectiveness of Its Eradication
After the skin, the gastrointestinal tract is the second most common target of systemic sclerosis (SSc). The aims of this study were to investigate orocecal transit time (OCTT) and the presence of small intestinal bacterial overgrowth (SIBO) in SSc as a cause of intestinal symptoms. (more)
Effect of a Community Screening for Helicobacter pylori: A 5-Yr Follow-Up Study
Helicobacter pylori (H. pylori) screening and eradication may reduce the incidence of gastric cancer, peptic ulcer, and ulcer complications, and it may reduce symptoms in a small proportion of individuals with functional dyspepsia. This study aimed to assess the effect of community H. pylori screening and treatment on the prevalence of dyspepsia, and as secondary outcomes, the effect on dyspepsia-related health-care consumption and quality of life over 5 years. (more)
Highlights from the current issue
Is virtual reality simulation an effective training method in surgery?
Virtual reality simulation as a training method for surgery has been available for more than a decade. Despite investigation into this technique, the desired widespread implementation of this training strategy has not been observed in clinical practice. This Viewpoint article discusses the advantages, disadvantages, current and future applications for virtual reality simulation in modern surgery. Click here to read the full text of this article.
Drug Insight: antiangiogenic therapies for gastrointestinal cancers—focus on monoclonal antibodies
Tumor angiogenesis – the formation of new tumor-associated vasculature – has been recognized as an essential event in tumor progression. Vascular endothelial growth factor (VEGF), one of the most important factors involved in tumor angiogenesis, is overexpressed in several gastrointestinal cancers. In this Review, the authors consider antiangiogenic therapy for the treatment of colorectal, gastric, hepatocellular and pancreatic cancer. Emphasis is placed on the mechanism of action and application of the humanized anti-VEGF monoclonal antibody bevacizumab, but other potential antiangiogenic targets and therapies are also discussed. Click here to read the full text of this article.
Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease
This Case Study describes a female with ileocolic Crohn's disease who was taking immunosuppressive therapy who presented with a 1-month history of bloody diarrhea, decreased caliber of stools, a broad indurated perianal fissure as well as a deep palmar space abscess. The patient was diagnosed with disseminated histoplasmosis. The authors of this article discuss the diagnosis and management of this patient and the importance of considering histoplasmosis in patients on immunosuppressive therapy who develop atypical symptoms. Click here to read the full text. CME is available for this article.
ACG SmartBrief, emailed twice weekly to ACG members,
provides summaries of the latest news in gastroenterology. You’ll
find news coverage of Clinical Updates, Legal & Regulatory,
Practice News, Business & Market Trends, Patient Perspectives,
and more. If you are an ACG member and are not currently receiving ACG
SmartBrief, update your member record by adding your email
address information.
Coming soon, search past issues of ACG SmartBrief to
find articles of interest.
You may request a free copy on any of the monographs listed below
by visiting the ACG Store. Many of these monographs are for
ACG members only.
IBD & Osteoporosis:
A Guide to Diagnosis and Management (2001)
Managing
Variceal Bleeding in the Cirrhotic (1996)
You may download a copy of the monograph listed below by clicking on the link.
Pregnancy in Gastrointestinal Disorders (Updated 2007)
|
